Decreasing Shigellosis-related Deaths withoutShigellaspp.–specific Interventions, Asia
Open Access
- 1 November 2010
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (11), 1718-1723
- https://doi.org/10.3201/eid1611.090934
Abstract
In 1999, a review of the literature for 1966–1997 suggested that ≈1.1 million persons die annually of shigellosis, including ≈880,000 in Asia. Our recent review of the literature for 1990–2009 indicates that ≈125 million shigellosis cases occur annually in Asia, of which ≈14,000 are fatal. This estimate for illnesses is similar to the earlier estimate, but the number of deaths is 98% lower; that is, the lower estimate of deaths is associated with markedly reduced case-fatality rates rather than fewer cases. Shigella spp.–related deaths decreased substantially during a period without Shigella spp.–specific interventions. We speculate that nonspecific interventions, e.g., measles vaccination, vitamin A supplementation, and improved nutrition, may have led to the reduced number of shigellosis-related deaths.Keywords
This publication has 28 references indexed in Scilit:
- Micronutrients and AnaemiaJournal of Health, Population and Nutrition, 2009
- Nutrition: Basis for Healthy Children and Mothers in BangladeshJournal of Health, Population and Nutrition, 2009
- Part II. Analysis of data gaps pertaining toShigellainfections in low and medium human development index countries, 1984–2005Epidemiology and Infection, 2007
- Childhood diarrhoea management practices in Bangladesh: private sector dominance and continued inequities in careInternational Journal of Epidemiology, 2006
- A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and MicrobiologyPLoS Medicine, 2006
- Phase I Evaluation of Δ virG Shigella sonnei Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy AdultsInfection and Immunity, 2002
- Attenuated Shigella flexneri 2a Δ guaBA Strain CVD 1204 Expressing Enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 Fimbriae as a Live Mucosal Vaccine against Shigella and ETEC InfectionInfection and Immunity, 2001
- Safety and Immunogenicity ofShigella sonneiandShigella flexneri2a O‐Specific Polysaccharide Conjugates in ChildrenThe Journal of Infectious Diseases, 1999
- Antimicrobial Resistance in Organisms Causing Diarrheal DiseaseClinical Infectious Diseases, 1997
- Mortality Due to Shigellosis: Community and Hospital DataClinical Infectious Diseases, 1991